🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 05464T104
- Market Cap
- Large Cap · $3 Billion
- IPO
- 11/19/2015 · $9.00/share
Business: Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel therapies for the management of pain and other central nervous system disorders. By focusing on this therapeutic area, Axsome is addressing significant and growing markets where current treatment options are limited or inadequate. Axsome’s product candidate portfolio includes two late-stage candidates, AXS-02 and AXS-05, which are being developed for multiple indications.
Company Contact
- CEO
- Herriot Tabuteau
- CFO
- Nick Pizzie
- Headquarters
- 200 Broadway, 3rd Floor New York, NY 10004
- Phone
- 212-332-3241
- Fax
- 212-320-0245
- Investor Relations
- Mark Jacobson · 212-332-3243 · mjacobson@axsome.com